[Therapy of coronary insufficiency with a combination of a coronary dilator and a beta-adrenergic blockader].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy*; D003374:Coumarins / Q000627:therapeutic use*; D004338:Drug Combinations; D006016:Glycolates / Q000627:therapeutic use*; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use*; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D003374:Coumarins; D004338:Drug Combinations; D006016:Glycolates; D010627:Phenethylamines; D014665:Vasodilator Agents; D006919:Hydroxyzine
Terapija koronarne insuficijencije kombinacijom koronarnih dilatatora i beta-adrenergicnih blokatora.